Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, June 18, 2013
Technology Networks
 
Register | Sign in
Home Page
  News
Return to the previous page

Avastin Improves Survival for Patients with Cervical Cancer

Published: Friday, February 08, 2013
Last Updated: Thursday, February 07, 2013
Bookmark and Share
According to an interim analysis of a clinical trial, patients lived a median 3.7 months longer than those who did not receive bevacizumab.

Full access to this article is for registered users only.
Registration is free-of-charge and allows access to all content on our web communities.

Already registered? Then please log in at the top of the page.

Print page

Scientific News
Two Gene Variants May Predict Who Will Benefit from Breast Cancer Prevention Drugs
NIH-supported discovery could advance individualized care of high-risk women.
Supreme Court Rules That Human Genes Can’t Be Patented
Most agree that the ruling reduces barriers to genetic testing and enables scientists to further genetic research and share data aimed ultimately at preventing and curing disease.
Researchers Find Unique Peptide with Therapeutic Potential
UTSW researchers identify Tat-beclin 1 against cancers, neurological disorders, and infectious diseases.
Genetic Switches Play Big Role in Human Evolution
Study offers further proof that the divergence of humans from chimpanzees was profoundly influenced by mutations to DNA sequences.
An Epigenetic Change Causes the Block of Antitumor Genes
Healthy cells live in a delicate balance between growth-promoting genes (oncogenes) and those who restrain it (anti-oncogenes or tumor suppressor genes).
Vegetable Fats Tied to Less Prostate Cancer Spread
After being diagnosed with prostate cancer, men who eat a diet high in vegetable fats may be less likely to have their disease spread.
Studies Illuminate Functions of RNA
Researchers at the University of California illuminate the functional importance of a relatively new class of RNA molecules.
Therapeutic Nanoparticles from Grapefruit Juice
Grapefruit-derived nanovectors to deliver targeted drugs to treat cancer.
Chemical Screen Points to New Line of Attack Against Neuroblastoma
In the war on neuroblastoma, the current chemical weaponry is reaching its limit.
Identified a Key Protein in Maintaining the Identity of B Lymphocytes
This finding could be useful for the study of blood diseases such as lymphoma and leukemia.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv
Go to ePosters.net